Literature DB >> 24012392

Targeting angiogenesis and the tumor microenvironment.

Jennifer Samples1, Monte Willis, Nancy Klauber-Demore.   

Abstract

The role of the microenvironment during the initiation and progression of malignancy is appreciated to be of critical importance for improved molecular diagnostics and therapeutics. The tumor microenvironment is the product of a crosstalk between different cells types. Active contribution of tumor-associated stromal cells to cancer progression has been recognized. Stromal elements consist of the extracellular matrix, fibroblasts of various phenotypes, and a scaffold comprised of immune and inflammatory cells, blood and lymph vessels, and nerves. This review focuses on therapeutic targets in the microenvironment related to tumor endothelium, tumor associated fibroblasts, and the extracellular matrix.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Growth factors; Integrins; Tumor associated fibroblast; Tumor microenvironment

Mesh:

Substances:

Year:  2013        PMID: 24012392      PMCID: PMC3780975          DOI: 10.1016/j.soc.2013.06.002

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  67 in total

1.  Genes expressed in human tumor endothelium.

Authors:  B St Croix; C Rago; V Velculescu; G Traverso; K E Romans; E Montgomery; A Lal; G J Riggins; C Lengauer; B Vogelstein; K W Kinzler
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

2.  Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

Authors:  Peter Vajkoczy; Mohammad Farhadi; Andreas Gaumann; Regina Heidenreich; Ralf Erber; Andreas Wunder; Jörg C Tonn; Michael D Menger; Georg Breier
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 3.  Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.

Authors:  Jack Lawler
Journal:  J Cell Mol Med       Date:  2002 Jan-Mar       Impact factor: 5.310

4.  Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.

Authors:  Yan Huang; Avis E Simms; Anna Mazur; Sophie Wang; Noel R León; Barry Jones; Nazneen Aziz; Thomas Kelly
Journal:  Clin Exp Metastasis       Date:  2011-05-22       Impact factor: 5.150

Review 5.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

6.  Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Authors:  Eric Raymond; Laetitia Dahan; Jean-Luc Raoul; Yung-Jue Bang; Ivan Borbath; Catherine Lombard-Bohas; Juan Valle; Peter Metrakos; Denis Smith; Aaron Vinik; Jen-Shi Chen; Dieter Hörsch; Pascal Hammel; Bertram Wiedenmann; Eric Van Cutsem; Shem Patyna; Dongrui Ray Lu; Carolyn Blanckmeister; Richard Chao; Philippe Ruszniewski
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

Review 7.  Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling.

Authors:  Scott M Wilhelm; Lila Adnane; Philippa Newell; Augusto Villanueva; Josep M Llovet; Mark Lynch
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

8.  Molecular characterization of human breast tumor vascular cells.

Authors:  Rajendra Bhati; Cam Patterson; Chad A Livasy; Cheng Fan; David Ketelsen; Zhiyuan Hu; Evangeline Reynolds; Catherine Tanner; Dominic T Moore; Franco Gabrielli; Charles M Perou; Nancy Klauber-DeMore
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

Review 9.  IGF-1 receptor inhibitors in clinical trials--early lessons.

Authors:  S John Weroha; Paul Haluska
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-21       Impact factor: 2.673

10.  The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus.

Authors:  Sharareh Siamakpour-Reihani; Joseph Caster; Desh Bandhu Nepal; Andrew Courtwright; Eleanor Hilliard; Jerry Usary; David Ketelsen; David Darr; Xiang Jun Shen; Cam Patterson; Nancy Klauber-Demore
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240

View more
  19 in total

1.  Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks.

Authors:  B R Achyut; Adarsh Shankar; A S M Iskander; Roxan Ara; Kartik Angara; Peng Zeng; Robert A Knight; Alfonso G Scicli; Ali S Arbab
Journal:  Cancer Lett       Date:  2015-09-21       Impact factor: 8.679

Review 2.  Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.

Authors:  Esak Lee; Niranjan B Pandey; Aleksander S Popel
Journal:  Expert Rev Mol Med       Date:  2015-01-30       Impact factor: 5.600

3.  Endostatin reverses immunosuppression of the tumor microenvironment in lung carcinoma.

Authors:  Xiaolin Liu; Weiwei Nie; Qi Xie; Guoling Chen; Xingyu Li; Yanrui Jia; Beibei Yin; Xun Qu; Yan Li; Jing Liang
Journal:  Oncol Lett       Date:  2017-11-21       Impact factor: 2.967

4.  MicroRNAs and cancer: Key paradigms in molecular therapy.

Authors:  Weige Tan; Bodu Liu; Shaohua Qu; Gehao Liang; Wei Luo; Chang Gong
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

Review 5.  Customizable biomaterials as tools for advanced anti-angiogenic drug discovery.

Authors:  Eric H Nguyen; William L Murphy
Journal:  Biomaterials       Date:  2018-07-26       Impact factor: 12.479

Review 6.  The roles of ADAMTS in angiogenesis and cancer.

Authors:  Yi Sun; Jintuan Huang; Zuli Yang
Journal:  Tumour Biol       Date:  2015-04-28

Review 7.  Hyaluronan and RHAMM in wound repair and the "cancerization" of stromal tissues.

Authors:  Cornelia Tolg; James B McCarthy; Arjang Yazdani; Eva A Turley
Journal:  Biomed Res Int       Date:  2014-08-04       Impact factor: 3.411

8.  CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer.

Authors:  Lichao Sun; Yipeng Wang; Hebao Yuan; Joseph Burnett; Jian Pan; Zhihua Yang; Yuliang Ran; Ila Myers; Duxin Sun
Journal:  J Cancer       Date:  2016-06-18       Impact factor: 4.207

9.  Human mesenchymal stem cells are resistant to cytotoxic and genotoxic effects of cisplatin in vitro.

Authors:  Bruno Corrêa Bellagamba; Bianca Regina Ribas de Abreu; Ivana Grivicich; Carolina Franke Markarian; Eduardo Chem; Melissa Camassola; Nance Beyer Nardi; Rafael Rodrigues Dihl
Journal:  Genet Mol Biol       Date:  2016-03       Impact factor: 1.771

10.  Vascular Mimicry: The Next Big Glioblastoma Target.

Authors:  Ali S Arbab; Meenu Jain; B R Achyut
Journal:  Biochem Physiol       Date:  2015-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.